The Canadian government is set to commit its largest single investment to date to support TRIUMF, the country's particle accelerator center.
Canada's 2019 federal budget includes a $292.7 million Canadian ($220 million U.S.) investment for TRIUMF's recently published five-year plan for 2020 to 2025. The funding is designed to bolster TRIUMF's portfolio of activities in science and technology, people and skills, and innovation and collaboration -- and to ensure the country's continued global competitiveness.
TRIUMF's five-year plan covers the following:
- The Advanced Rare Isotope Laboratory (ARIEL), a multidisciplinary research facility for isotope research in science, medicine, and business
- The Institute for Advanced Medical Isotopes (IAMI), a center for the research and development of new isotope-based medical technologies
- TRIUMF Innovations, a commercialization engine translating TRIUMF's discoveries into commercial opportunities
"Today's announcement sends a strong message of support for Canadian science and its role in Canada's research and innovation ecosystem," said Dr. Jonathan Bagger, TRIUMF's director. "TRIUMF's vision is for Canada to lead not only in discovery but also in technology, innovation, and training so that our country will continue to develop the people and skills necessary for translating science to society."
